Skip to content

13F-HR/A filed by Eversept Partners, LP

Eversept Partners, LP filed this 13F-HR/A for the quarter ended 2020-09-30, filed 2020-11-13, with 48 holding rows worth $444,615,000.

Accession
0001697013-20-000008
Filed
2020-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2020

A holdings report, amendment of type restatement, 48 entries on the cover page, a total value of $444,615,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $444,615,000 with VALUE read as thousands by filing date, 13F file number 028-18369. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
HORIZON THERAPEUTICS PLCG46188101SHS607,757$47,211,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW10,653,459$44,851,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock1,023,330$27,384,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR161,004$24,846,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock240,904$24,331,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR2,394,355$21,573,000thousands by filing date
FATE THERAPEUTICS INC31189P102COM535,036$21,385,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM321,581$20,906,000thousands by filing date
DECIPHERA PHARMACEUTICALS IN24344T101COM402,433$20,645,000thousands by filing date
ENSIGN GROUP INC29358P101COM318,863$18,210,000thousands by filing date
HESKA CORP42805E306COM158,772$15,685,000thousands by filing date
ZOGENIX INC.98978L204Common Stock865,241$15,514,000thousands by filing date
CATALENT INC USD 0.01148806102COM140,329$12,021,000thousands by filing date
ORASURE TECHNOLOGIES INC68554V108COM940,412$11,445,000thousands by filing date
AMNEAL PHARMACEUTICALS INC03168L105COM STK CL A2,656,208$10,306,000thousands by filing date
STANDARD BIOTOOLS INC34385P108COM1,302,353$9,676,000thousands by filing date
QIAGEN NVN72482123SHS NEW167,473$8,752,000thousands by filing date
TARO PHARMACEUTICAL INDS LTDM8737E108SHS141,889$7,783,000thousands by filing date
Danaher Corporation235851102COM31,360$6,758,000thousands by filing date
MODEL N INC607525102COM188,967$6,667,000thousands by filing date
HCA Healthcare Inc40412C101COM52,400$6,533,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock435,995$6,422,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM98,501$5,169,000thousands by filing date
MYLAN NVN59465109SHS EURO324,951$4,819,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK176,758$4,536,000thousands by filing date
AFFIMED N VN01045108COM1,245,458$4,222,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock1,143,211$3,927,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS293,277$3,431,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR60,936$3,339,000thousands by filing date
Mersana Therapeutics Inc59045L106Common Stock140,000$2,607,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR49,778$2,497,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR64,372$2,453,000thousands by filing date
APELLIS PHARMACEUTICALS INC03753U106COM81,267$2,452,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW150,494$2,232,000thousands by filing date
SESEN BIO INC817763105COM1,559,824$2,184,000thousands by filing date
QUIDEL CORP74838J101COM9,343$2,050,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock197,028$1,968,000thousands by filing date
OTONOMY INC68906L105COM412,500$1,671,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM107,300$1,351,000thousands by filing date
CONCERT PHARMACEUTICALS INC206022105COM103,829$1,020,000thousands by filing date
LIQUIDIA CORPORATION COM NEW53635D202Stock182,751$899,000thousands by filing date
SOLID BIOSCIENCES INC COM NEW83422E105Stock307,024$623,000thousands by filing date
PROTARA THERAPEUTICS INC74365U107COM STK36,310$611,000thousands by filing date
AMARIN CORPORATION PLC -ADR023111906ADR12,854$504,000thousands by filing date
SCPHARMACEUTICALS INC810648105COM65,605$489,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM1,897$266,000thousands by filing date
TELIGENT INC NEW COM NEW87960W203COM305,423$220,000thousands by filing date
GOHEALTH INC38046W105COM CL A13,130$171,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001697013-20-000007 superseded2020-11-12acceptance time not in the bulk data set
13F-HR/A 0001697013-20-000008this filing2020-11-13acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000017 base2023-11-08acceptance time not in the bulk data set
13F-HR/A 0001697013-23-000018 added2023-11-08acceptance time not in the bulk data set